Mustang Bio (MBIO) Financials: Revenue & Earnings
MBIO$0.36+0.00 +0.14%
$2.42M
Market Cap
-0.80
P/E
—
Forward P/E
51
Score
Mustang Bio (MBIO) Financials: Revenue & Earnings
MBIO price $0.36 +0.00 +0.14%
- Ticker
- MBIO
- Price
- $0.36
- Change
- +0.00 +0.14%
- Market cap ?
- $2.42M
- P/E ?
- -0.80
- Dividend yield ?
- 0.00%
- Beta ?
- 2.09
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 51
- Value
- 58
- Quality
- 46
- Growth
- 50
Stocklytics score rationale: value 58, quality 46, growth 50.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination…
Fair value
MBIO fair value Not meaningful. Price $0.36.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-18 | — | -140.00 | — | — |
| 2026-08-05 | -0.16 | -140.00 | — | — |
| 2026-05-05 | -0.14 | -140.00 | — | — |
| 2026-03-19 | -0.08 | -5.50 | — | — |
| 2025-11-07 | -0.07 | — | — | — |
| 2025-08-08 | -0.19 | — | — | — |
| 2025-05-14 | -0.05 | — | — | — |
| 2025-03-24 | -37.95 | -5.50 | — | — |
| 2024-11-08 | -2.00 | -6.50 | — | — |
| 2024-08-13 | -12.00 | -7.00 | — | — |
| 2024-05-15 | -23.00 | -0.87 | — | — |
| 2024-03-11 | -35.50 | -84.00 | 2.88M | — |
| 2023-11-14 | -61.50 | -94.00 | — | — |
| 2023-08-14 | -100.00 | -103.50 | — | — |
| 2023-05-12 | -103.00 | -142.50 | — | — |
| 2023-03-29 | -134.93 | -142.43 | — | — |
| 2022-11-14 | -2.42 | -0.20 | — | — |
| 2022-08-11 | -142.43 | -157.42 | — | — |
| 2022-05-12 | -149.93 | -134.93 | — | — |
| 2022-03-23 | -164.92 | -157.42 | — | — |
| 2021-11-12 | -142.43 | -134.93 | — | — |
| 2021-08-16 | -119.94 | -149.93 | — | — |
| 2021-05-14 | -142.43 | -149.93 | — | — |
| 2021-03-24 | -239.88 | -157.42 | — | — |
| 2020-11-06 | -172.41 | -194.90 | — | — |
| 2020-08-10 | -239.88 | -209.90 | — | — |
| 2020-05-11 | -209.90 | -254.87 | — | — |
| 2020-03-16 | -314.84 | -187.41 | — | — |
| 2019-11-12 | -187.41 | -202.40 | — | — |
| 2019-08-09 | -217.39 | -179.91 | — | — |
| 2019-05-10 | -254.87 | -277.36 | — | — |
| 2019-03-18 | -329.84 | -202.40 | -50.00K | — |
| 2018-11-13 | -209.90 | -149.93 | — | 35.71K |
| 2018-08-13 | -142.43 | -187.41 | — | 65.79K |
| 2018-05-14 | -179.91 | -172.41 | 50.00K | 47.92K |
| 2018-03-29 | -164.92 | -179.91 | — | — |
| 2017-11-14 | -3.98 | — | — | — |
| 2017-08-14 | -3.16 | — | — | — |
| 2017-05-15 | -1.84 | — | — | — |
| 2017-03-31 | -5.00 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-04-24 | Litchman Manuel MD | Sell | 19 | $0.75 | 14 |
| 2026-01-02 | Fortress Biotech, Inc. | Buy | 278.38K | — | — |
| 2025-12-30 | Herskowitz Neil | Sell | 247 | $0.96 | 238 |
| 2025-12-30 | Chill Adam J. | Sell | 4 | $0.95 | 4 |
| 2025-12-30 | Jin David | Buy | 247 | $0.96 | 238 |
| 2025-09-29 | Fortress Biotech, Inc. | Buy | 59.33K | — | — |
| 2025-04-24 | Litchman Manuel MD | Sell | 27 | $1.24 | 33 |
| 2025-03-31 | Fortress Biotech, Inc. | Buy | 67.81K | — | — |
| 2024-12-31 | Fortress Biotech, Inc. | Other | 0 | — | — |
| 2024-10-23 | Jin David | Other | 0 | — | — |
| 2024-06-27 | Fortress Biotech, Inc. | Buy | 575.19K | — | — |
| 2024-05-31 | Litchman Manuel MD | Sell | 1.40K | $0.35 | 489 |
| 2024-01-19 | MURPHY JAMES B | Other | 0 | — | — |
| 2024-01-02 | Fortress Biotech, Inc. | Buy | 419.09K | — | — |
| 2023-12-11 | Carney Peter | Sell | 0 | — | — |
| 2023-07-05 | ZELEFSKY MICHAEL J | Buy | 7.25K | — | — |
| 2023-07-05 | Chill Adam J. | Buy | 7.25K | — | — |
| 2023-07-05 | ROSENWALD LINDSAY A MD | Buy | 7.25K | — | — |
| 2023-07-05 | WEISS MICHAEL S | Buy | 7.25K | — | — |
| 2023-07-05 | Herskowitz Neil | Buy | 7.25K | — | — |
| 2023-04-24 | Litchman Manuel MD | Sell | 1.57K | $4.21 | 6.62K |
| 2023-04-24 | Litchman Manuel MD | Buy | 5.00K | — | — |
| 2023-01-06 | Fortress Biotech, Inc. | Buy | 2.81M | — | — |
| 2022-09-13 | Litchman Manuel MD | Buy | 5.00K | $0.52 | 2.58K |
| 2022-09-13 | ROSENWALD LINDSAY A MD | Buy | 5.00K | $0.52 | 2.58K |
| 2022-07-29 | ROSENWALD LINDSAY A MD | Buy | 71.66K | — | — |
| 2022-07-29 | Herskowitz Neil | Buy | 71.66K | — | — |
| 2022-07-29 | ZELEFSKY MICHAEL J | Buy | 71.66K | — | — |
| 2022-07-29 | Chill Adam J. | Buy | 71.66K | — | — |
| 2022-07-29 | WEISS MICHAEL S | Buy | 71.66K | — | — |
| 2022-06-21 | Litchman Manuel MD | Buy | 61.00K | — | — |
| 2022-04-24 | Litchman Manuel MD | Sell | 1.25K | $12.15 | 15.16K |
| 2022-04-18 | Lurier Eliot M | Sell | 0 | — | — |
| 2022-03-18 | Litchman Manuel MD | Buy | 5.00K | $0.74 | 3.69K |
| 2022-03-18 | ROSENWALD LINDSAY A MD | Buy | 4.09K | $0.74 | 3.03K |
| 2021-12-14 | Achenbach Brian | Sell | 4.37K | $1.83 | 8.00K |
| 2021-12-08 | Achenbach Brian | Buy | 22.50K | — | — |
| 2021-10-27 | Litchman Manuel MD | Buy | 65.00K | $2.24 | 145.60K |
| 2021-10-12 | Achenbach Brian | Sell | 4.45K | $2.28 | 10.15K |
| 2021-08-31 | ROSENWALD LINDSAY A MD | Buy | 1.17K | $2.58 | 3.02K |
| 2021-08-31 | Litchman Manuel MD | Buy | 2.75K | $2.58 | 7.08K |
| 2021-07-30 | Litchman Manuel MD | Buy | 86.21K | $2.91 | 250.86K |
| 2021-06-28 | ZELEFSKY MICHAEL J | Buy | 13.77K | — | — |
| 2021-06-28 | WEISS MICHAEL S | Buy | 13.77K | — | — |
| 2021-06-28 | ROSENWALD LINDSAY A MD | Buy | 13.77K | — | — |
| 2021-06-28 | Herskowitz Neil | Buy | 13.77K | — | — |
| 2021-06-28 | Chill Adam J. | Buy | 13.77K | — | — |
| 2021-06-17 | Litchman Manuel MD | Buy | 61.00K | — | — |
| 2021-04-09 | Achenbach Brian | Sell | 2.42K | $3.36 | 8.14K |
| 2021-03-05 | Litchman Manuel MD | Buy | 165.56K | $3.12 | 516.55K |
| 2021-02-26 | Litchman Manuel MD | Buy | 5.00K | $2.83 | 14.15K |
| 2021-02-26 | ROSENWALD LINDSAY A MD | Buy | 1.04K | $2.83 | 2.95K |
| 2020-12-15 | Achenbach Brian | Buy | 22.50K | — | — |
| 2020-12-15 | Litchman Manuel MD | Buy | 100.00K | $2.91 | 291.00K |
| 2020-12-14 | ROSENWALD LINDSAY A MD | Buy | 100.00K | $2.66 | 266.00K |
| 2020-12-14 | ROSENWALD LINDSAY A MD | Buy | 100.00K | $2.66 | 266.00K |
| 2020-12-08 | Achenbach Brian | Sell | 5.18K | $3.03 | 15.71K |
| 2020-10-21 | Achenbach Brian | Sell | 3.06K | $2.97 | 9.08K |
| 2020-09-15 | Litchman Manuel MD | Buy | 61.00K | — | — |
| 2020-08-31 | ROSENWALD LINDSAY A MD | Buy | 1.18K | $2.48 | 2.93K |
| 2020-08-31 | Litchman Manuel MD | Buy | 5.00K | $2.48 | 12.40K |
| 2020-07-14 | ROSENWALD LINDSAY A MD | Buy | 16.61K | $2.48 | 41.20K |
| 2020-07-14 | ZELEFSKY MICHAEL J | Buy | 16.61K | — | — |
| 2020-07-14 | WEISS MICHAEL S | Buy | 16.61K | — | — |
| 2020-07-14 | ROSENWALD LINDSAY A MD | Buy | 16.61K | — | — |
| 2020-07-14 | Herskowitz Neil | Buy | 16.61K | — | — |
| 2020-07-14 | Chill Adam J. | Buy | 16.61K | — | — |
| 2020-06-11 | Litchman Manuel MD | Buy | 153.85K | $3.25 | 500.00K |
| 2020-05-22 | Litchman Manuel MD | Sell | 4.03K | $3.04 | 12.24K |
| 2020-05-22 | Litchman Manuel MD | Sell | 8.35K | $3.04 | 25.38K |
| 2020-05-22 | Achenbach Brian | Sell | 880 | $3.04 | 2.68K |
| 2020-05-21 | Litchman Manuel MD | Buy | 90.00K | $3.13 | 281.70K |
| 2020-05-14 | Litchman Manuel MD | Buy | 90.00K | $2.79 | 251.10K |
| 2020-03-31 | Achenbach Brian | Sell | 3.03K | $2.64 | 8.01K |
| 2020-03-26 | Litchman Manuel MD | Buy | 122.00K | — | — |
| 2020-03-26 | Achenbach Brian | Buy | 36.25K | — | — |
| 2020-03-05 | Litchman Manuel MD | Buy | 5.00K | $2.48 | 12.40K |
| 2020-03-05 | Achenbach Brian | Buy | 524 | $2.48 | 1.30K |
| 2020-02-28 | ROSENWALD LINDSAY A MD | Buy | 831 | $2.48 | 2.06K |
| 2019-12-06 | Achenbach Brian | Sell | 6.14K | $3.69 | 22.67K |
| 2019-08-28 | Herskowitz Neil | Buy | 13.81K | — | — |
| 2019-08-28 | Chill Adam J. | Buy | 13.81K | — | — |
| 2019-08-28 | WEISS MICHAEL S | Buy | 13.81K | — | — |
| 2019-08-28 | ROSENWALD LINDSAY A MD | Buy | 13.81K | — | — |
| 2019-04-16 | Achenbach Brian | Buy | 35.00K | — | — |
| 2018-12-10 | Litchman Manuel MD | Buy | 8.00K | $3.35 | 26.80K |
| 2018-12-04 | Litchman Manuel MD | Buy | 7.50K | $3.60 | 27.00K |
| 2018-11-26 | Litchman Manuel MD | Buy | 5.00K | $3.87 | 19.35K |
| 2018-11-23 | Herskowitz Neil | Buy | 1.00K | $3.96 | 3.96K |
| 2018-11-21 | Litchman Manuel MD | Buy | 5.00K | $4.21 | 21.05K |
| 2018-11-20 | Litchman Manuel MD | Buy | 2.50K | $3.89 | 9.72K |
| 2018-11-20 | Achenbach Brian | Buy | 500 | $3.87 | 1.94K |
| 2018-11-19 | Achenbach Brian | Buy | 1.00K | $4.25 | 4.25K |
| 2018-11-16 | Achenbach Brian | Buy | 1.00K | $4.31 | 4.31K |
| 2018-11-12 | Chill Adam J. | Buy | 1.00K | $4.85 | 4.85K |
| 2018-11-08 | Chill Adam J. | Buy | 2.00K | $5.34 | 10.68K |
| 2018-11-02 | ROSENWALD LINDSAY A MD | Buy | 50.00K | $4.41 | 220.50K |
| 2018-06-14 | WEISS MICHAEL S | Buy | 10.00K | — | — |
| 2018-06-14 | ROSENWALD LINDSAY A MD | Buy | 10.00K | — | — |
| 2018-06-14 | Herskowitz Neil | Buy | 10.00K | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 23, holders +1 vs prior quarter. Ownership 8.01%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| KESTRA ADVISORY SERVICES, LLC | 196.99K | 20.95K | +11.90% | 138.29K |
| BLACKROCK, INC. | 84.75K | 0 | 0.00% | 59.49K |
| CITADEL ADVISORS LLC | 59.46K | 6.26K | +11.77% | 41.74K |
| GEODE CAPITAL MANAGEMENT, LLC | 42.24K | -50.55K | -54.48% | 29.65K |
| CFO4LIFE GROUP, LLC | 33.51K | 13.05K | +63.77% | 23.52K |
| VANGUARD FIDUCIARY TRUST CO | 32.12K | 0 | 0.00% | 22.55K |
| VANGUARD CAPITAL MANAGEMENT LLC | 25.70K | 0 | 0.00% | 18.04K |
| XTX TOPCO LTD | 14.65K | 14.65K | New | 10.28K |
| VIRTU FINANCIAL LLC | 14.36K | 14.36K | New | 10.00K |
| TWO SIGMA SECURITIES, LLC | 13.74K | 13.74K | New | 9.65K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 13.66K | 13.66K | New | 9.59K |
| UBS GROUP AG | 4.16K | 496 | +13.56% | 2.92K |
| TOWER RESEARCH CAPITAL LLC (TRC) | 1.90K | 0 | 0.00% | 1.33K |
| BARCLAYS PLC | 1.12K | 1.12K | New | 787 |
| SBI SECURITIES CO., LTD. | 509 | 0 | 0.00% | 357 |
| MORGAN STANLEY | 118 | 0 | 0.00% | 83 |
| CULLEN/FROST BANKERS, INC. | 13 | 0 | 0.00% | 9 |
| BNP PARIBAS FINANCIAL MARKETS | 6 | 0 | 0.00% | 4 |
| LANARK FINANCIAL, INC. | 3 | 0 | 0.00% | 2 |
| JPMORGAN CHASE & CO | 2 | 0 | 0.00% | 1 |
| DANSKE BANK A/S | 2 | 0 | 0.00% | 1 |
| OSAIC HOLDINGS, INC. | 2 | 0 | 0.00% | 1 |
| GROUP ONE TRADING LLC | 1 | 0 | 0.00% | 1 |
| TWO SIGMA INVESTMENTS, LP | 0 | -16.75K | -100.00% | 0 |
| MAI CAPITAL MANAGEMENT | 0 | -3 | -100.00% | 0 |
Earnings and financials
Mustang Bio, Inc. (MBIO) trades at $0.36, with a market cap of $2.42M and a trailing P/E of -0.80. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Insights · Dividends · Forecast · Financials · Learn